Abundance Wealth Counselors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Buy
+2,950
New +$153K 0.01% 297
2024
Q2
Sell
-4,863
Closed -$518K 117
2024
Q1
$518K Buy
4,863
+835
+21% +$84.2K 0.12% 102
2023
Q4
$401K Buy
4,028
+42
+1% +$3.53K 0.1% 109
2023
Q3
$412K Sell
3,986
-498
-11% -$55.5K 0.12% 101
2023
Q2
$545K Sell
4,484
-74
-2% -$9.87K 0.28% 40
2023
Q1
$700K Buy
4,558
+106
+2% +$17.5K 0.18% 83
2022
Q4
$800K Sell
4,452
-131
-3% -$21.4K 0.22% 72
2022
Q3
$542K Buy
4,583
+87
+2% +$13.2K 0.15% 85
2022
Q2
$642K Buy
4,496
+612
+16% +$87.5K 0.17% 80
2022
Q1
$669K Buy
+3,884
New +$654K 0.18% 78

Other funds holding MRNA

Abundance Wealth Counselors's MRNA Position: Q2 2026 in Review

Abundance Wealth Counselors opened a new position in Moderna (MRNA) in Q2 2026: 2,950 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #297 among its holdings. This is a return to the name: Abundance Wealth Counselors previously reported a position in MRNA as recently as Q1 2024.

Abundance Wealth Counselors first reported a position in MRNA in Q1 2022 and has held it in 10 quarters since. The position peaked at $800K in Q4 2022. 164 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Abundance Wealth Counselors held 2,950 shares of Moderna worth $207K as of Q2 2026.
  • Moderna was a new Abundance Wealth Counselors position in Q2 2026.
  • Moderna made up 0.01% of Abundance Wealth Counselors's portfolio in Q2 2026, its #297 holding.
  • Abundance Wealth Counselors first reported a position in Moderna in Q1 2022 and has held it in 10 quarters since.
  • Abundance Wealth Counselors's Moderna position peaked at $800K in Q4 2022.
  • 164 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Abundance Wealth Counselors's 13F filing for Q2 2026, filed 23 Jul 2026.